RNAi Screening for Therapeutic Targets in Human Malignancies

Author(s): David R. Micklem, James B. Lorens

Journal Name: Current Pharmaceutical Biotechnology

Volume 8 , Issue 6 , 2007

Become EABM
Become Reviewer
Call for Editor


The advent of RNA interference (RNAi) based library screening approaches has sparked a surge in loss-of-function genetic screens. Several recent screens have aimed to identify novel regulators of cancer-related phenotypes. These employ various tumor cell types to model malignant cell functions and use different RNAi effector library approaches to reveal a cache of novel tumor regulators. This review surveys recent RNAi screens conducted in transformed human cells.

Keywords: RNA interference, genetic screen, cancer, therapeutic target

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [337 - 343]
Pages: 7
DOI: 10.2174/138920107783018426
Price: $65

Article Metrics

PDF: 2